 | | Tipranavir (Aptivus) |  | | Published
July 13, 2005; Updated
October 19, 2011 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-09 | | | Selected References | | 4. | Boehringer Ingelheim Pharmaceuticals, Inc. Tipranavir Anti-Viral Drugs Advisory Committee (AVDAC) Briefing Document. April 19, 2005. Available at: www.fda.gov/ohrms/dockets/ac/05/briefing/2005-4139b1-02-boehringer.pdf. | |
| 6. | Aptivus [package insert]. Boehringer Ingelheim GmbH, Germany; 2006. Available at: www.fda.gov/medwatch/safety/2006/Aptivus_PI.pdf | |
| 7. | Walmsley S, Leith J, Katlama C, et al. Pharmacokinetics and safety of tipranavir/ritonavir (TPV/r) alone and in combination with saquinavir (SQV), amprenavir (APV), or lopinavir (LPV): Interim analysis of BI1182.51. In: Program and abstracts of the XV International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract WeOrB1236. | |
|
|
|
